183 related articles for article (PubMed ID: 34392579)
1. Treatment preferences for primary membranous nephropathy: Results of a multinational survey among nephrologists in the South Asia Pacific region.
Bose B; Badve SV; Johnson DW; Hawley C; Jha V; Reidlinger D; Peh CA
Nephrology (Carlton); 2022 Jan; 27(1):35-43. PubMed ID: 34392579
[TBL] [Abstract][Full Text] [Related]
2. Tacrolimus combined with corticosteroids versus Modified Ponticelli regimen in treatment of idiopathic membranous nephropathy: Randomized control trial.
Ramachandran R; Hn HK; Kumar V; Nada R; Yadav AK; Goyal A; Kumar V; Rathi M; Jha V; Gupta KL; Sakhuja V; Kohli HS
Nephrology (Carlton); 2016 Feb; 21(2):139-46. PubMed ID: 26205759
[TBL] [Abstract][Full Text] [Related]
3. Recent Clinical Trials Insights into the Treatment of Primary Membranous Nephropathy.
Rojas-Rivera J; Fervenza FC; Ortiz A
Drugs; 2022 Feb; 82(2):109-132. PubMed ID: 34932208
[TBL] [Abstract][Full Text] [Related]
4. Japanese clinical practice patterns of primary nephrotic syndrome 2021: a web-based questionnaire survey of certified nephrologists.
Wada T; Shimizu S; Koizumi M; Sofue T; Nishiwaki H; Sasaki S; Nakaya I; Oe Y; Ishimoto T; Furuichi K; Okada H; Kurita N
Clin Exp Nephrol; 2023 Sep; 27(9):767-775. PubMed ID: 37310570
[TBL] [Abstract][Full Text] [Related]
5. Immunosuppressive regimens based on Cyclophospamide or Calcineurin inhibitors: Comparison of their effect in the long term outcome of Primary Membranous Nephropathy.
Stangou M; Marinaki S; Papachristou E; Kolovou K; Sambani E; Zerbala S; Papadea P; Balafa O; Rapsomanikis KP; Andrikos A; Manolakaki P; Papadopoulou D; Mitsopoulos E; Liakou H; Andronikidi PE; Choulitoudi V; Moustakas G; Galitsiou D; Dafnis E; Stylianou K; Stefanidis I; Golfinopoulos S; Panagoutsos S; Tsilivigkou M; Papadogianakis A; Tzanakis I; Sioulis A; Vlachakos D; Grapsa E; Spaia S; Kaperonis N; Paliouras C; Dioudis C; Papoulidou F; Apostolou T; Iatrou C; Boletis I; Goumenos D; Papagianni A
PLoS One; 2019; 14(8):e0217116. PubMed ID: 31404062
[TBL] [Abstract][Full Text] [Related]
6. Management of Membranous Nephropathy in Western Countries.
Alfaadhel T; Cattran D
Kidney Dis (Basel); 2015 Sep; 1(2):126-37. PubMed ID: 27536673
[TBL] [Abstract][Full Text] [Related]
7. Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency. Study Group.
Branten AJ; Wetzels JF
Clin Nephrol; 2001 Jul; 56(1):1-9. PubMed ID: 11499653
[TBL] [Abstract][Full Text] [Related]
8. Rituximab versus steroids and cyclophosphamide for the treatment of primary membranous nephropathy: protocol of a pilot randomised controlled trial.
Scolari F; Dallera N; Gesualdo L; Santoro D; Pani A; Santostefano M; Feriozzi S; Mani LY; Boscutti G; Messa P; Magistroni R; Quaglia M; Ponticelli C; Ravani P
BMJ Open; 2019 Dec; 9(12):e029232. PubMed ID: 31806605
[TBL] [Abstract][Full Text] [Related]
9. Advances in the Management of Primary Membranous Nephropathy and Rituximab-Refractory Membranous Nephropathy.
Teisseyre M; Cremoni M; Boyer-Suavet S; Ruetsch C; Graça D; Esnault VLM; Brglez V; Seitz-Polski B
Front Immunol; 2022; 13():859419. PubMed ID: 35603210
[TBL] [Abstract][Full Text] [Related]
10. Treatment of idiopathic membranous nephropathy in adults: KDIGO 2012, cyclophosphamide and cyclosporine A are out, rituximab is the new normal.
Rojas-Rivera JE; Carriazo S; Ortiz A
Clin Kidney J; 2019 Oct; 12(5):629-638. PubMed ID: 31583088
[TBL] [Abstract][Full Text] [Related]
11. Kidney biopsy practice amongst Australasian nephrologists.
Burke JP; Pham T; May S; Okano S; Ratanjee SK; Thet Z; Wong JKW; Venuthurupalli S; Ranganathan D
BMC Nephrol; 2021 Aug; 22(1):291. PubMed ID: 34445981
[TBL] [Abstract][Full Text] [Related]
12. Practice patterns of rituximab for primary membranous nephropathy 2021 in Japan: a web-based survey of board-certified nephrologists.
Miyaoka Y; Kurita N; Sofue T; Nishiwaki H; Koizumi M; Shimizu S; Sasaki S; Ishimoto T; Wada T
Clin Exp Nephrol; 2024 Mar; 28(3):217-224. PubMed ID: 37924431
[TBL] [Abstract][Full Text] [Related]
13. Cyclical cyclophosphamide and steroids is effective in resistant or relapsing nephrotic syndrome due to M-type phospholipase A2 receptor-related membranous nephropathy after tacrolimus therapy.
Ramachandran R; Kumar V; Jha V
Kidney Int; 2016 Jun; 89(6):1401-2. PubMed ID: 27181781
[No Abstract] [Full Text] [Related]
14. Treatment of progressive membranous glomerulopathy. A randomized trial comparing cyclophosphamide and corticosteroids with corticosteroids alone. The Glomerular Disease Collaborative Network.
Falk RJ; Hogan SL; Muller KE; Jennette JC
Ann Intern Med; 1992 Mar; 116(6):438-45. PubMed ID: 1371211
[TBL] [Abstract][Full Text] [Related]
15. Management of Membranous Nephropathy in Asia.
Xu J; Hu X; Xie J; Chen N
Kidney Dis (Basel); 2015 Sep; 1(2):119-25. PubMed ID: 27536672
[TBL] [Abstract][Full Text] [Related]
16. Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome.
Chen Y; Schieppati A; Chen X; Cai G; Zamora J; Giuliano GA; Braun N; Perna A
Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD004293. PubMed ID: 25318831
[TBL] [Abstract][Full Text] [Related]
17. Treatment of membranous nephropathy.
Ponticelli C; Passerini P
Nephrol Dial Transplant; 2001; 16 Suppl 5():8-10. PubMed ID: 11509678
[TBL] [Abstract][Full Text] [Related]
18. Calcineurin inhibitors versus cyclophosphamide for idiopathic membranous nephropathy: A systematic review and meta-analysis of 21 clinical trials.
Qiu TT; Zhang C; Zhao HW; Zhou JW
Autoimmun Rev; 2017 Feb; 16(2):136-145. PubMed ID: 27988429
[TBL] [Abstract][Full Text] [Related]
19. The STARMEN trial: rethinking calcineurin inhibitor therapy in membranous nephropathy.
Floege J; Rovin BH
Kidney Int; 2021 Apr; 99(4):811-813. PubMed ID: 33745547
[TBL] [Abstract][Full Text] [Related]
20. Intravenous pulse cyclophosphamide and steroids induce immunological and clinical remission in New-incident and relapsing primary membranous nephropathy.
Kanigicherla DAK; Hamilton P; Czapla K; Brenchley PE
Nephrology (Carlton); 2018 Jan; 23(1):60-68. PubMed ID: 27778424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
